--- title: "Top 10 HK Stock Gainers (4.30)" type: "News" locale: "en" url: "https://longbridge.com/en/news/284725279.md" description: "ILUVATAR COREX(09903) rose 21.3%, with a trading turnover 1.1 Billion HKD, and a year-to-date rose 222.1%. GUANZE MEDICAL(02427) rose 12.41%, with a trading turnover 21.9 Million HKD, and a year-to-date rose 1335.8%. HAIXI PHARMA(02637) rose 9.21%, with a trading turnover 300.5 Million HKD, and a year-to-date rose 91.9%." datetime: "2026-04-30T08:31:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284725279.md) - [en](https://longbridge.com/en/news/284725279.md) - [zh-HK](https://longbridge.com/zh-HK/news/284725279.md) --- # Top 10 HK Stock Gainers (4.30) Hang Seng Index has fell 1.28%, with a year-to-date rose 0.6%; Hang Seng TECH Index has fell 0.79%, with a year-to-date fell 11.7%. ILUVATAR COREX(09903) rose 21.3%, with a trading turnover 1.1 Billion HKD, and a year-to-date rose 222.1%. GUANZE MEDICAL(02427) rose 12.41%, with a trading turnover 21.9 Million HKD, and a year-to-date rose 1335.8%. HAIXI PHARMA(02637) rose 9.21%, with a trading turnover 300.5 Million HKD, and a year-to-date rose 91.9%. ### Related Stocks - [09903.HK](https://longbridge.com/en/quote/09903.HK.md) - [02427.HK](https://longbridge.com/en/quote/02427.HK.md) - [02637.HK](https://longbridge.com/en/quote/02637.HK.md) - [09636.HK](https://longbridge.com/en/quote/09636.HK.md) - [06082.HK](https://longbridge.com/en/quote/06082.HK.md) - [06600.HK](https://longbridge.com/en/quote/06600.HK.md) - [00981.HK](https://longbridge.com/en/quote/00981.HK.md) - [02940.HK](https://longbridge.com/en/quote/02940.HK.md) - [00004.HK](https://longbridge.com/en/quote/00004.HK.md) - [01516.HK](https://longbridge.com/en/quote/01516.HK.md) ## Related News & Research - [OneRobotics Wins Shareholder Backing for Incentive Plan and Wealth Management Moves](https://longbridge.com/en/news/283680603.md) - [Fujian Haixi Pharmaceuticals Revamps Hong Kong Company Secretarial Roles](https://longbridge.com/en/news/278064864.md) - [Shanghai Biren Sets 2026 AGM to Vote on Board, Capital Mandates and Governance Changes](https://longbridge.com/en/news/283571502.md) - [Fujian Haixi Advances First-in-Class Oral Retinal Drug HXP056 Into Phase II](https://longbridge.com/en/news/280291010.md) - [Shanghai Iluvatar CoreX Unveils New H Share Incentive Scheme](https://longbridge.com/en/news/281032444.md)